ALKERMES reported 217.86M in Gross Profit on Sales for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
Acadia Pharmaceuticals ACAD:US $ 131.9M 19.38M
Acorda Therapeutics ACOR:US $ 22.25M 5.68M
Amgen AMGN:US $ 5084M 407M
Biogen BIIB:US $ 2105.1M 327.2M
Biomarin Pharmaceutical BMRN:US $ 410.67M 8.28M
Bluebird Bio BLUE:US $ -226000 6.14M
Bristol Myers Squibb BMY:US $ 9210M 33M
Eli Lilly And LLY:US $ 5057.5M 680.4M
Gilead Sciences GILD:US $ 4818M 348M
Horizon Pharma HZNP:US $ 646.2M 23.99M
Intra Cellular Therapies ITCI:US $ 50.93M 19.09M
IONIS PHARMACEUT IONS:US $ 129.05M 8.7M
JAZZ PHA JAZZ:US $ 808.67M 110.23M
Johnson & Johnson JNJ:US $ 16101M 273M
Marinus Pharmaceuticals MRNS:US 1.79M 11.23M
Merk MRK:US $ 10895M 328M
Nektar Therapeutics NKTR:US $ 16.47M 3.04M
Neurocrine Biosciences NBIX:US $ 373.4M 67.4M
Otsuka Holdings 4578:JP Y 286052M 32084M
Pfizer PFE:US $ 19071M 3420M
Regeneron Pharmaceuticals REGN:US $ 2560.1M 0.1M
Revance Therapeutics RVNC:US $ 18.84M 1.48M
Teva Pharmaceutical Industries TEVA:US $ 1828M 26M
Vertex Pharmaceuticals VRTX:US $ 1934.4M 82.7M